With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.65202-50-8,Methyl 6-chloropyridazine-3-carboxylate,as a common compound, the synthetic route is as follows.,65202-50-8
:p 3: Methyl 6-(3- { [2-(trifluoromethyl)benzylloxyl azetidin- 1 -yl)pyridazine-3- carboxylate; A suspension of 3-{[2-(trifluoromethyl)benzyl]oxy}azetidine (595 mg, 2.58 mmol), methyl beta-chloropyridazine-S-carboxylate (450 mg, 2.58 mmol), potassium carbonate (715 mg, 5.15 mmol) and tetrabutylammonium iodide (20 mg, 0.052 mmol) in dioxane (10 mL) was heated to 95 ¡ãC for 16 h. The cooled reaction mixture was poured into a 125 mL separatory funnel containing water (50 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and concentrated. Purification by column chromatography through silica gel gave the title compound.1H NMR (J6-acetone, 400 MHz) delta 7.86-7.80 (2H, m), 7.75-7.51 (3H, m), 6.79 (IH, d, J= 9.5 Hz), 4.78-4.76 (3H, m), 4.49 (2H, dd, J= 10.0, 6.5 Hz), 4.15 (2H, dd, J= 10.0, 4.0 Hz), 3.88 (3H, s).MS (ESI, Q+) m/z 368 (M+ 1).
As the paragraph descriping shows that 65202-50-8 is playing an increasingly important role.
Reference£º
Patent; MERCK FROSST CANADA LTD.; WO2007/143823; (2007); A1;,
Pyridazine – Wikipedia
Pyridazine | C4H4N2 – PubChem